Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-06 Option Award | 2023-06-08 9:34 pm | N/A 2033-06-05 | Marker Therapeutics Inc. | MRKR | Knobil Katharine Director | 8,000 | $0 | 8,000 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-08 5:19 pm | N/A 2033-06-07 | PLIANT THERAPEUTICS INC. | PLRX | Knobil Katharine Director | 14,000 | $0 | 14,000 (Direct) | View |
| 2022-09-14 Option Award | 2022-09-16 6:08 pm | N/A 2032-09-13 | PLIANT THERAPEUTICS INC. | PLRX | Knobil Katharine Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 4:10 pm | N/A 2032-05-23 | Marker Therapeutics Inc. | MRKR | Knobil Katharine Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-03-11 Other | 2022-03-11 4:23 pm | N/A N/A | ARENA PHARMACEUTICALS INC | ARNA | Knobil Katharine Director | 6,821 | $0 | 6,821 (Direct) | View |
| 2022-03-11 Disposition | 2022-03-11 4:23 pm | N/A N/A | ARENA PHARMACEUTICALS INC | ARNA | Knobil Katharine Director | 14,702 | $0 | 6,821 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-09 5:20 pm | N/A 2031-12-07 | Marker Therapeutics Inc. | MRKR | Knobil Katharine Director | 125,000 | $0 | 125,000 (Direct) | View |
Ownership | 2021-12-09 5:18 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Knobil Katharine Director | 0 | $0 | 1,500 (Indirect) | View |
| 2021-06-11 Option Award | 2021-06-15 5:28 pm | N/A 2028-06-11 | ARENA PHARMACEUTICALS INC | ARNA | Knobil Katharine Director | 10,269 | $0 | 14,023 (Direct) | View |
| 2020-10-15 Option Award | 2020-10-19 07:38 am | N/A 2030-10-14 | Kaleido Biosciences Inc. | KLDO | Knobil Katharine Chief Medical Officer | 67,500 | $0 | 67,500 (Direct) | View |
| 2020-06-12 Option Award | 2020-06-16 7:38 pm | N/A 2027-06-12 | ARENA PHARMACEUTICALS INC | ARNA | Knobil Katharine Director | 11,169 | $0 | 11,254 (Direct) | View |
Ownership | 2020-06-16 7:27 pm | N/A N/A | ARENA PHARMACEUTICALS INC | ARNA | Knobil Katharine Director | 0 | $0 | 85 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 08:00 am | N/A 2030-04-14 | Kaleido Biosciences Inc. | KLDO | Knobil Katharine See Remarks | 67,500 | $0 | 67,500 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 9:05 pm | N/A N/A | Kaleido Biosciences Inc. | KLDO | Knobil Katharine See Remarks | 15,843 | $0 | 15,843 (Direct) | View |
| 2019-11-15 Option Award | 2019-11-18 4:06 pm | N/A 2029-11-14 | Kaleido Biosciences Inc. | KLDO | Knobil Katharine See Remarks | 175,000 | $0 | 175,000 (Direct) | View |